How to Treat OCD: Therapy, Medication, and What the Evidence Shows

Most people with OCD are not receiving the treatment that works for it. Not because effective treatment does not exist, it does, but because the treatment that works requires specific training that most mental health providers have not received.

OCD is one of the most studied and most treatable psychiatric conditions. The gold-standard treatment has been established for over 30 years. The medications that work are well-understood and broadly available. Yet only about 2 percent of OCD patients have documented evidence in their medical records of receiving exposure and response prevention therapy, the specific form of CBT that is the gold standard treatment for OCD.

This is the central clinical problem in OCD care. Understanding what effective treatment actually looks like is the first step toward getting it.

What This Page Covers

• What ERP is and why it is the gold standard
• How SSRIs work for OCD and why they require different dosing than for depression
• When combined ERP plus medication outperforms either alone
• What high-dose SSRI treatment looks like and why it matters
• The augmentation sequence when first-line approaches fall short
• Adjunctive therapies: ACT, DBT, and what the evidence supports
• Why most people with OCD are not getting effective treatment
• How SiggyMD supports OCD co-occurring with anxiety and depression

Exposure and Response Prevention: Why It Is the Gold Standard

ERP is a structured, specialized form of cognitive behavioral therapy designed specifically for OCD. It is not general talk therapy. It is a protocol that works by targeting the obsession-compulsion cycle at its most vulnerable point.

The cycle: an obsessive thought triggers anxiety, a compulsion temporarily relieves it, relief reinforces the compulsion, and the cycle strengthens. ERP breaks this loop by preventing the compulsion while allowing the anxiety to rise and then naturally diminish without a compulsive response.

Research shows that ERP effectively reduces compulsive behaviors even for people who do not respond well to medication. With ERP, people spend time in a safe environment that gradually exposes them to situations that trigger their obsession while preventing the typical compulsive behavior. Although this approach initially causes anxiety, compulsions decrease for most people as they continue treatment.

The exposures are planned hierarchically, working from lower-anxiety triggers to higher ones. They are practiced both in session and between sessions. The learning that occurs is inhibitory: the brain discovers that the feared outcome does not happen, and that the anxiety is tolerable and temporary without the compulsion.

Approximately 75 to 80 percent of people with OCD improve with ERP. Meta-analyses consistently demonstrate that ERP produces significant symptom reduction compared to placebo and pharmacological treatment. The barrier is access, not efficacy.

What to Ask a Therapist

If you have been diagnosed with OCD, ask explicitly: Are you trained in ERP for OCD specifically? General CBT training does not include OCD-specific ERP protocols. A therapist trained in CBT but not OCD ERP cannot provide effective OCD treatment. The International OCD Foundation (iocdf.org) maintains a directory of ERP-trained providers.

SSRIs for OCD: How and Why They Work Differently

SSRIs are the first-line pharmacological treatment for OCD, with five FDA-approved agents: fluoxetine, fluvoxamine, paroxetine, sertraline, and clomipramine. SSRIs and clomipramine are the only medications found to be effective standalone treatments for OCD.

The serotonin pathways involved in OCD run through the cortico-striato-thalamo-cortical (CSTC) circuit, which shows hyperactivity in OCD. SSRIs modulate this circuit, reducing the intensity of the error-detection signal that drives obsessions.

Why OCD Requires Higher Doses

OCD often requires medication at higher doses and for longer durations than other conditions, particularly when using SSRIs. A psychiatrist trained in OCD will be more comfortable adjusting dosages appropriately and monitoring for therapeutic effect and side effects.

For depression, an SSRI at a moderate dose is often clinically effective. For OCD, guidelines typically require doses at or near the top of the FDA-approved range, and the APA allows occasional prescribing above standard maximums. Whereas high-dose SSRIs have been linked to increased side effects without increased efficacy for major depressive disorder, a meta-analysis found that for patients with OCD, higher SSRI doses were associated with greater efficacy than low or medium doses.

Why OCD Requires Longer Trials

Initial improvement in OCD symptoms with pharmacotherapy may not be evident until at least 4 to 6 weeks of treatment. Treatment guidelines broadly support requiring 8 to 12 weeks at target dose before assessing response. Many people stop OCD medication trials within three to four weeks, before the medication has reached therapeutic dose and before the therapeutic window has opened.

A failed OCD medication trial that was conducted at a low dose for four weeks is not evidence that SSRIs do not work for that person. It is evidence that the trial was inadequate.

“The most common mistake I see with OCD medication management is undertreating: starting at a low dose and never titrating appropriately, then concluding after three weeks that the medication doesn’t work,” says Daniel Montville, MD, Psychiatrist, of the SiggyMD clinical team. “OCD needs higher doses and longer trials than depression. If someone has been on a standard antidepressant dose for OCD for a month, they haven’t had an adequate OCD trial.”

When to Combine ERP and Medication

For mild to moderate OCD, ERP monotherapy and SSRI monotherapy are each effective options. For moderate to severe OCD, a combination of CBT/ERP and an SSRI is recommended. Clinical experience supports the combined approach for more severe symptoms.

The clinical logic: SSRIs reduce the raw intensity of obsessive anxiety, which makes it less overwhelming to engage with ERP exposures. ERP produces the lasting cognitive and behavioral changes that medication alone does not. They work on different mechanisms and are complementary.

Combining ERP with medication is a common treatment plan for many with OCD. Clinical experience tells us that a combined approach may be better for people with more severe symptoms and comorbid mental health conditions.

Clomipramine: The High-Evidence Alternative

Clomipramine is a tricyclic antidepressant with some of the strongest evidence in OCD treatment. For certain patients, particularly those who have not responded to multiple SSRI trials, clomipramine can produce improvement where SSRIs have not.

Clomipramine is one of the most effective pharmacologic options for OCD, active against both obsessional thinking and compulsive behaviors. It carries more side effects including dry mouth, constipation, dizziness, and weight gain. Cardiac considerations apply: an ECG is typically obtained before prescribing, especially in older patients or those with cardiac history.

Clomipramine is reserved for use when SSRIs have failed, not as a first-line option, because of its side effect burden. But it remains clinically important in the OCD treatment sequence.

Augmentation Strategies When First-Line Fails

When an adequate trial of an SSRI at therapeutic dose and duration produces only partial response, the options are clear.

Antipsychotic augmentation. When used to augment SSRIs in the treatment of OCD, low-dose atypical antipsychotics are the class of medications with the greatest evidence for efficacy. Approximately one-third of patients who do not have satisfactory responses to an SSRI alone will respond when a low-dose antipsychotic is added. Aripiprazole and risperidone have the most evidence.

Switching SSRIs. Despite failure of one SSRI, patients often respond to a second SSRI, though response rates are somewhat lower than for the first trial.

Adding ERP to medication. If someone has been on medication but not in ERP, adding ERP is a high-value next step. The behavioral intervention targets a mechanism that medication does not address.

SSRIs remain the first-line medications for treating OCD. When SSRI treatment fails: optimize the SSRI dose; switch to an alternative agent; augment with an additional medication such as an antipsychotic. ERP and somatic treatments should also be considered.

Adjunctive Therapies

Beyond ERP, several other therapeutic approaches add value as supplements, not replacements, for primary OCD treatment.

Acceptance and Commitment Therapy (ACT). ACT focuses on psychological flexibility and acceptance of obsessive thoughts without compulsive responses. It is particularly useful as an adjunct for people who have difficulty engaging with traditional ERP exposures or who have residual symptoms after an ERP course.

Dialectical Behavior Therapy (DBT). DBT’s distress tolerance and mindfulness skills can help people with OCD manage the anxiety that arises during ERP without resorting to compulsions. DBT can be used as a supplement to ERP because it provides skills to respond effectively when urges to engage in compulsions arise.

Mindfulness-Based Therapy. Mindfulness supports the psychological stance ERP requires: allowing obsessive thoughts to be present without responding to them as though they were instructions. Mindfulness-based therapy has been found to be an effective adjunct to ERP by helping people with OCD shift away from the reactive fear and distress that arises from symptoms toward a mindset of acceptance and detachment.

Why the OCD Treatment Gap Persists

The gap between available evidence and actual practice in OCD care is one of the largest in psychiatry.

Only 2 percent of OCD patients have documented evidence of receiving ERP in their medical records, despite it being the effective treatment for over 30 years. More than 72 percent of OCD patients are not referred for ERP or CBT at all. The problem is not patient resistance. It is clinician training.

Most mental health providers are not trained in OCD-specific ERP. General CBT training does not include OCD protocols. A clinician who sees OCD and offers standard talk therapy or general CBT without ERP is providing care that will not address the specific mechanism that maintains the disorder.

The most important clinical action for most people with OCD is finding a therapist specifically trained in ERP for OCD. The International OCD Foundation directory is the best starting point.

About SiggyMD

SiggyMD provides clinically supervised care for anxiety and depression, including in people who have OCD alongside co-occurring mood and anxiety conditions.

Many people with OCD live with significant anxiety and depression as comorbid conditions. Getting medication management right for those co-occurring conditions, using an SSRI at an appropriate dose with ongoing monitoring, can make a substantial difference in how much bandwidth is available for the work of ERP.

SiggyMD does not replace OCD-specific ERP therapy. What it provides is the clinical oversight for anxiety and depression co-occurring with OCD: daily check-ins, real-time prescriber review, and dose adjustments based on how the medication is actually working over time.

For more on OCD specifically, see our guides on what OCD is and how it develops and the four types of OCD.

Start your anonymous intake with SiggyMD to connect with a prescriber who can evaluate the full clinical picture, including OCD co-occurring with anxiety or depression, and support the medication management piece of a comprehensive treatment plan.

What Members Are Saying

AB

A.B., 29

OCD with Comorbid Anxiety

“I was on a standard antidepressant dose for years without improvement, and kept being told I had tried medication and it didn’t work. When I finally saw a psychiatrist who knew OCD, he explained that I had never been on an OCD dose. We tripled the dose over the course of several months and the difference was enormous. I wish someone had told me earlier that the dosing requirements are completely different.”

TK

T.K., 37

OCD with ERP

“I saw four therapists before I found one trained in ERP. The others were helpful people, but they were treating my OCD with general CBT techniques that did not address the actual mechanism. Two months of real ERP did more than two years of the other approaches. If you have OCD, the specific type of therapy matters more than almost anything else.”

Member stories reflect real experiences. Names and identifying details have been changed to protect privacy. Results vary. You can begin anonymous intake without an account, name, email, or payment.

The Bottom Line

Effective OCD treatment is available and evidence-based. ERP is the psychological gold standard, with 75 to 80 percent of people seeing meaningful improvement with proper protocols. SSRIs at higher doses and longer durations than for depression are the pharmacological first line. Combined treatment outperforms either alone for moderate to severe OCD.

The clinical problem is access. Most people with OCD are not receiving ERP because most clinicians are not trained in it. If you have OCD, asking specifically for an ERP-trained therapist and for a medication review that accounts for OCD-specific dosing requirements are the two highest-value clinical actions.

If you are in crisis or having thoughts of self-harm, call or text 988. If you are in immediate danger, call 911.

Sources

1. National Institute of Mental Health. Obsessive-Compulsive Disorder: When Unwanted Thoughts or Repetitive Behaviors Take Over. NIMH. Accessed June 2026.

2. International OCD Foundation. OCD Treatment Guide. IOCDF. Accessed June 2026.

3. International OCD Foundation. Full Report: Americas OCD Care Crisis. December 2025.

4. IOCDF. Medication for OCD. Accessed June 2026.

5. ADAA (Dr. Sharon Batista). How Medications Support Effective OCD Treatment. Accessed June 2026.

6. Katzman MA, et al. Clinical practice guidelines for Obsessive-Compulsive Disorder. BMC Psychiatry. 2014.

7. Dougherty DD, et al. Moving beyond first-line treatment options for OCD. CNS Spectrums. 2022.

8. Pittenger C, et al. Pharmacotherapy for Treatment-Resistant Obsessive-Compulsive Disorder. Pharmacological Reviews. 2020.

9. PMC. 2025 Clinical Practice Guidelines for Obsessive-Compulsive Disorder. 2025.

10. Advanced Psychiatry Associates. OCD Pharmacology: High-Dose SSRIs, Augmentation, and Where ERP Fits In. Accessed June 2026.